BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation needle forms to ensure no contamination of the culture, the sterile mediums, and the surrounding environment. In inoculation the inoculation needle is first employed to transfer microbial life forms from a culture to the needle to be used in further inoculating procedures. Sources of inoculum include broth cultures, slant cultures, and plate cultures. An inoculation needle is used in the transfer of microorganisms from a broth culture by first employing a vortex mixer to ensure a uniform suspension of the microorganisms within the broth. Aseptic technique is then applied to the needle. Once the needle is flamed and sterilized the culture